{"id":428,"date":"2026-10-30T10:56:00","date_gmt":"2026-10-30T09:56:00","guid":{"rendered":"https:\/\/equicord.com\/?page_id=428"},"modified":"2026-10-30T10:56:21","modified_gmt":"2026-10-30T09:56:21","slug":"nuevos-desarrollos","status":"publish","type":"page","link":"https:\/\/equicord.com\/en\/nuevos-desarrollos\/","title":{"rendered":"New Developments"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\n\t\n<\/svg>\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

DogStem<\/span><\/p>

The Future: Systemic Pathologies<\/h1>

Numerous scientific publications support the efficacy and safety of stem cells in the treatment of systemic diseases such as chronic kidney failure or inflammatory bowel disease (IBD).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

In recent years, the intravenous use of stem cells has been investigated to treat numerous systemic and autoimmune diseases due to their immunomodulatory potential, but there is still no stem cell-based drug authorized for this use.<\/p>

  • Kidney failure<\/li>
  • IBD<\/li>
  • Atopic dermatitis<\/li>
  • Eye problems<\/li>
  • Wounds<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\n<\/div>\n\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
    \n\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\n\t\n<\/svg>\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\n\t\n<\/svg>\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    Do you want to participate in our clinical trials?<\/h2>

    EquiCord is committed to the research and development of new, advanced therapy drugs that offer long-term solutions for veterinarians. Mesenchymal stem cells, thanks to their potent anti-inflammatory and immunomodulatory action, have proven to be an effective and safe treatment for numerous diseases, with a lasting effect after a single administration.<\/p>

    Inflammatory bowel disease (IBD)<\/strong> is a chronic, serious, and debilitating illness with a mortality rate exceeding 30%. It is characterized by vomiting, diarrhea, weight loss, fatigue, and a reduced quality of life.<\/p>

    Until now, IBD<\/strong> has been managed with high doses of immunosuppressants, which leads to serious side effects.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

    \n\t\t\t\t\t\t\t\t\t

    Results from pilot studies have shown:<\/strong><\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t
    \n \t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t

    CORTICOSTEROID WITHDRAWAL<\/p>\t\t\t

    \n\t\t\t\t<\/span>\n\t\t\t\t0<\/span>\n\t\t\t\t%<\/span>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
    \n\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t

    REMISSION OF CLINICAL SYMPTOMS<\/p>\t\t\t

    \n\t\t\t\t<\/span>\n\t\t\t\t0<\/span>\n\t\t\t\t%<\/span>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
    \n\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t

    IMPROVING QUALITY OF LIFE<\/p>\t\t\t

    \n\t\t\t\t<\/span>\n\t\t\t\t0<\/span>\n\t\t\t\t%<\/span>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\n<\/div>\n\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

    DogStem El Futuro: Patolog\u00edas sist\u00e9micas Numerosas publicaciones cient\u00edficas apoyan la eficacia y seguridad de las c\u00e9lulas madre en el tratamiento de enfermedades sist\u00e9micas como la insuficiencia renal cr\u00f3nica o la enfermedad inflamatoria intestinal (IBD). En los \u00faltimos a\u00f1os se ha indagado en el uso intravenoso de las c\u00e9lulas madre para tratar numerosas patolog\u00edas sist\u00e9micas y […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_canvas","meta":{"footnotes":""},"class_list":["post-428","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/equicord.com\/en\/wp-json\/wp\/v2\/pages\/428","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/equicord.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/equicord.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/equicord.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/equicord.com\/en\/wp-json\/wp\/v2\/comments?post=428"}],"version-history":[{"count":4,"href":"https:\/\/equicord.com\/en\/wp-json\/wp\/v2\/pages\/428\/revisions"}],"predecessor-version":[{"id":434,"href":"https:\/\/equicord.com\/en\/wp-json\/wp\/v2\/pages\/428\/revisions\/434"}],"wp:attachment":[{"href":"https:\/\/equicord.com\/en\/wp-json\/wp\/v2\/media?parent=428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}